Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Find the Advantages of Deep rooted Getting the hang of: Extending Information and Self-awareness - 2The Best Computer games for Multiplayer Fun
- 3Interpreter Starts Sobbing as 11-Year-Old Testifies About Last Time He Saw His Mom Before She Was Killed in Missile Strike
- 4From Modesty to Administration: Self-improvement in Interactive abilities
- 5Wegovy maker Novo sharpens consumer focus with board role for Mars CEO
- France honors the victims of the Paris attacks' night of terror 10 years on
- Figure out How to Score Huge with Open Record Rewards
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- Israel Police decry online defamation campaign against female officer in Jerusalem
- Top Smoothie Flavor: What's Your Mix?
- Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide
- An Ideal Getaway - Spots for Solo Travel
- Soldiers seize power in Guinea-Bissau and detain the president
- In blow to Lula, Brazil Congress revives controversial environmental bill
